Zoetis Inc. (ZTS) – Can Zoetis gain back its momentum?

in , , on September 19, 2022

This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.

Zoetis Inc. (ZTS)

ZTS operates as a global leader in animal healthcare products. There are other competitors in the market but Zoetis has the major market share. This industry is characterized by high costs related with drug manufacturing and supply.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 33

Release Information

  • Price
    :

    $99.00

  • Released
    :

    September 19, 2022

  • Last Updated
    :

    September 20, 2022